ANN D. RHOADS - 22 May 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Ann D. Rhoads
Issuer symbol
QDEL
Transactions as of
22 May 2024
Net transactions value
$0
Form type
4
Filing time
23 May 2024, 18:28:20 UTC
Previous filing
30 Jan 2024
Next filing
29 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units (Equity Grant) Award $0 +4,929 $0.000000 4,929 22 May 2024 Common Stock 4,929 Direct F1, F2
transaction QDEL Restricted Stock Units (Converted) Award $0 +1,173 $0.000000 1,173 22 May 2024 Common Stock 1,173 Direct F1, F3, F4
transaction QDEL Restricted Stock Units (Premium) Award $0 +234 $0.000000 234 22 May 2024 Common Stock 234 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2 The restricted stock units vest on May 22, 2025.
F3 The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
F4 293 shares vested on May 22, 2024, 293 shares will vest on August 22, 2024, 293 shares will vest on November 22, 2024 and 294 shares will vest on February 22, 2025.